Solventum (NYSE:SOLV – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 6.100-6.400 for the period, compared to the consensus EPS estimate of 6.270. The company issued revenue guidance of -.
Solventum Trading Down 4.1 %
SOLV stock traded down $2.71 on Thursday, hitting $63.72. The company’s stock had a trading volume of 2,017,106 shares, compared to its average volume of 2,877,894. Solventum has a 1 year low of $60.72 and a 1 year high of $96.05.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on SOLV shares. Wells Fargo & Company began coverage on Solventum in a report on Monday, April 8th. They issued an equal weight rating and a $69.00 price objective on the stock. Edward Jones assumed coverage on Solventum in a research report on Tuesday, April 2nd. They issued a hold rating for the company. Finally, Morgan Stanley assumed coverage on shares of Solventum in a research note on Wednesday, April 10th. They set an equal weight rating and a $70.00 price target on the stock.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Articles
- Five stocks we like better than Solventum
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is a Death Cross in Stocks?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.
